The Carlat Psychiatry Podcast podcast

A New FDA Approval Brings New Psychiatric Risks

0:00
16:43
Rewind 15 seconds
Fast Forward 15 seconds

The FDA just approved the cyclobenzaprine (Tonmya, Flexeril) for fibromyalgia. We look at three risks that medication raises in psychiatry.

CME: Take the CME Post-Test for this Episode

Published On: 09/01/2025

Duration: 16 minutes, 42 seconds

Chris Aiken, MD and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

More episodes from "The Carlat Psychiatry Podcast"